Health, Fitness & Food

Shortly after the opening bell, we will be exiting our position in Johnson & Johnson (JNJ), selling 500 shares at roughly $171 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in J & J. We are making the tough decision to exit our J & J position after the

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s antiviral

In this article BIIB Follow your favorite stocksCREATE FREE ACCOUNT A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the

In this article PFE MRNA NVAX Follow your favorite stocksCREATE FREE ACCOUNT A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California.  Justin Sullivan | Getty Images A federal bankruptcy judge on Friday rejected Johnson & Johnson‘s second attempt to resolve tens of thousands of

In this article GSK GSK-GB Follow your favorite stocksCREATE FREE ACCOUNT Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will

Attendees walk through an expo hall during Amazon Web Services’ Reinvent conference at the Venetian in Las Vegas on Nov. 29, 2022. Noah Berger | Getty Images Entertainment | Getty Images Amazon Web Services on Wednesday announced a new service for health care software providers called AWS HealthScribe, which uses generative artificial intelligence and speech recognition to

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes,

In this article NOVO.B-DK SAN-FR Follow your favorite stocksCREATE FREE ACCOUNT Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo

Halfpoint Images | Moment | Getty Images The Americans with Disabilities Act was signed into law 33 years ago to protect people with disabilities from discrimination. But the disabled still face major hurdles when it comes to building wealth. To help make it easier for disabled individuals with lower incomes to save, Sen. Bob Casey,

Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany this month, but it could be some time before

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care in focus ‘Ultimate trade-down play’ Watch the Bullpen 1. Health care in focus Club holdings Danaher (DHR) and GE Healthcare (GEHC) reported better-than-expected earnings before the bell Tuesday.

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson on

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent

A closely watched talc trial in California goes against Johnson & Johnson (JNJ), adding uncertainty around whether tens of thousands of other plaintiffs suing the company will sign on to J & J’s proposed $8.9 billion settlement offer or seek to get their own days in court. Jim Cramer believes the biopharmaceutical company was “too

Warning labels are designed to inform consumers about potential risks of using a product, but they have become too prevalent to be beneficial. “Warning labels really were fairly rare until the 1960s,” said W. Kip Viscusi, a distinguished professor of law, economics, and management at Vanderbilt University. “Beginning in the mid-1960’s, cigarettes started to have

In this article Follow your favorite stocksCREATE FREE ACCOUNT Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan Mcdermid | Reuters Most consumers have pulled back on spending as inflation squeezes their wallets,

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT In this aerial image, damage is seen to a Pfizer pharmaceutical factory after a tornado hit the facility two days earlier, on July 21, 2023 in Rocky Mount, North Carolina. Sean Rayford | Getty Images Pfizer on Friday said there does not appear to be

In this article AZN-GB SAN-FR Follow your favorite stocksCREATE FREE ACCOUNT A doctor is injecting a vaccine to a baby boy Karl Tapales | Moment | Getty Images Sanofi expects its infant RSV shot to roll out in the U.S. before respiratory virus season this fall, a company spokesperson said Friday. The Food and Drug

Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com . Reminder, we can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. Question 1: What are your thoughts on the stability of FORD’s dividend? Thank you, Denise The quickest